New hope for tough lymphomas? experimental drug brincidofovir enters global trial
NCT ID NCT06761677
First seen Jan 02, 2026 · Last updated May 17, 2026 · Updated 24 times
Summary
This study tests an experimental drug called brincidofovir given through a vein for people with lymphoma that has returned or not responded to prior therapy. The trial has two parts: first, finding the safest dose in up to 18 participants with various lymphomas, then testing that dose in 25 people with a specific type called extranodal NK/T-cell lymphoma. The goal is to see if the drug is safe and can shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY LYMPHOMA INCLUDING ENKL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Institute Hospital Of JFCR
Kōtoku, Japan
-
Kyoto University Hospital
Kyoto, Japan
-
Mie University Hospital
Tsu, Japan
-
National Cancer Center Hospital
Chūōku, Japan
-
National Cancer Centre Singapore
Singapore, Singapore
-
Okayama University Hospital
Okayama, Japan
-
Queen Mary Hospital
Hong Kong, China
-
Tokyo Metropolitan Komagome Hospital
Bunkyō City, Japan
Conditions
Explore the condition pages connected to this study.